1M6MYTD1Y5YMAX
Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Mar 2026 | |
|---|---|---|
| Revenue | 26.56K | 25.13% |
| Gross profit | 15.08K | 8.19% |
| Net profit | -104.68K | 79.01% |
| EBITDA | -97.03K | 79.53% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €4.61M |
Number of shares | 495.09M |
52-week high/low | €0.0124 - €0.00621 |
| Dividends | No |
Beta | 2.65 |
P/E ratio | -7.14 |
PEG ratio | -0.12 |
P/B ratio | 43.99 |
P/S ratio | 24.77 |
Company profile
Blueberries Medical Corp. beschäftigt sich mit dem Anbau, der Entwicklung, der Produktion und der Lieferung von medizinischem Cannabis und verwandten Produkten in Kolumbien. Das Unternehmen bietet Cannabisölextrakte in medizinischer Qualität und verwandte Produkte an. Der Hauptsitz des Unternehmens befindet sich in Bogotá, Kolumbien.
| Name | Blueberries Medical |
| CEO | Facundo Garreton |
| Headquarters | Vancouver,
bc Canada |
| Website | |
| IPO | 04/09/2014 |
| Employees | 51 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Pnk | BBRRF |
Cnq | BBM.CN |
Frankfurt | 1OA.F |
München | 1OA.MU |
Discover assets
Shareholders of Blueberries Medical also invest in the following assets
